Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Mucopolysaccharidosis (MPS) Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029

Table of Content

1. Executive Summary

       1.1. Global Market Outlook

       1.2. Demand Side Trends

       1.3. Supply Side Trends

       1.4. Analysis and Recommendations

2. Market Overview

       2.1. Market Coverage / Taxonomy

       2.2. Market Definition / Scope / Limitations

3. Key Market Trends

       3.1. Key Trends Impacting the Market

       3.2. Technological Developments 

4. Key Success Factors

       4.1. Regulatory Scenario

       4.2. Pipeline Analysis 

       4.3. Snapshot of Developments for Mucopolysaccharidosis Type 3

       4.4. Designed Designation

       4.5. Rare Disease Framework

5. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast, 2019-2029

       5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

       5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

              5.2.1. Y-o-Y Growth Trend Analysis

              5.2.2. Absolute $ Opportunity Analysis

6. Market Background

       6.1. Macro-Economic Factors

              6.1.1. Global GDP Growth Outlook

              6.1.2. Global Healthcare Expenditure Outlook

       6.2. Forecast Factors – Relevance & Impact

              6.2.1. Improved Services in Concerned Economies 

              6.2.2. Drug Candidates in Pipeline 

              6.2.3. Drug Approval Process in Different Economies 

              6.2.4. Growth in Production Capacity

              6.2.5. Change in Cost of Treatment 

       6.3. Market Dynamics

              6.3.1. Drivers

              6.3.2. Restraints

              6.3.3. Opportunity Analysis

7. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type 

       7.1. Introduction / Key Findings

       7.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014 – 2018

       7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 – 2029

              7.3.1. Enzyme Replacement Therapies

              7.3.2. Stem Cell Therapies

                     7.3.2.1. Bone Marrow Transplantation (BMT)

                     7.3.2.2. Umbilical Cord Blood Transplantation (UCBT)

       7.4. Market Attractiveness Analysis By Treatment Type 

8. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Type of MPS

       8.1. Introduction / Key Findings

       8.2. Historical Market Size (US$ Mn) Analysis By Type of MPS, 2014 – 2018

       8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type of MPS, 2019 – 2029

              8.3.1. MPS I

              8.3.2. MPS II

              8.3.3. MPS IV A

              8.3.4. MPS VI

              8.3.5. MPS VII

       8.4. Market Attractiveness Analysis By Type of MPS

9. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by End User 

       9.1. Introduction / Key Findings

       9.2. Historical Market Size (US$ Mn) Analysis By End User, 2014 – 2018

       9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019 – 2029

              9.3.1. Hospital 

              9.3.2. Specialty Clinics

              9.3.3. Medical Research Centers 

              9.3.4. Home-infusion

       9.4. Market Attractiveness Analysis By End User 

10. Global Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region

       10.1. Introduction

       10.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018

       10.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

              10.3.1. North America

              10.3.2. Latin America

              10.3.3. Europe

              10.3.4. East Asia

              10.3.5. South Asia 

              10.3.6. MEA

              10.3.7. Oceania

       10.4. Market Attractiveness Analysis By Region

11. North America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

       11.1. Introduction

       11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              11.3.1. By Country

                      11.3.1.1. U.S.

                      11.3.1.2. Canada

              11.3.2. By Treatment Type

              11.3.3. By Type of MPS

              11.3.4. By End User 

       11.4. Market Attractiveness Analysis

12. Latin America Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

       12.1. Introduction

       12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              12.3.1. By Country

                      12.3.1.1. Brazil

                      12.3.1.2. Mexico

                      12.3.1.3. Argentina

                      12.3.1.4. Rest of Latin America

              12.3.2. By Treatment Type

              12.3.3. By Type of MPS

              12.3.4. By End User 

       12.4. Market Attractiveness Analysis

13. Europe Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

       13.1. Introduction

       13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              13.3.1. By Country

                      13.3.1.1. Germany

                      13.3.1.2. Italy

                      13.3.1.3. France

                      13.3.1.4. U.K.

                      13.3.1.5. Spain

                      13.3.1.6. BENELUX

                      13.3.1.7. Russia

                      13.3.1.8. Rest of Europe

              13.3.2. By Treatment Type

              13.3.3. By Type of MPS

              13.3.4. By End User 

       13.4. Market Attractiveness Analysis

14. South Asia Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029

       14.1. Introduction

       14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              14.3.1. By Country

                      14.3.1.1. India

                      14.3.1.2. Thailand

                      14.3.1.3. Indonesia

                      14.3.1.4. Malaysia

                      14.3.1.5. Rest of South Asia

              14.3.2. By Treatment Type

              14.3.3. By Type of MPS

              14.3.4. By End User 

       14.4. Market Attractiveness Analysis

15. East Asia Hysteroscopy Systems Market Analysis 2014-2018 and Forecast 2019-2029

       15.1. Introduction

       15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              15.3.1. By Country

                      15.3.1.1. China

                      15.3.1.2. Japan

                      15.3.1.3. South Korea

              15.3.2. By Treatment Type

              15.3.3. By Type of MPS

              15.3.4. By End User 

       15.4. Market Attractiveness Analysis

16. Oceania Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

       16.1. Introduction

       16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              16.3.1. By Country

                      16.3.1.1. Australia

                      16.3.1.2. New Zealand

              16.3.2. By Treatment Type

              16.3.3. By Type of MPS

              16.3.4. By End User 

       16.4. Market Attractiveness Analysis

17. Middle East and Africa Mucopolysaccharidosis Treatment Market Analysis 2014-2018 and Forecast 2019-2029

       17.1. Introduction

       17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018

       17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029

              17.3.1. By Country

                      17.3.1.1. GCC Countries

                      17.3.1.2. South Africa

                      17.3.1.3. Rest of Middle East and Africa

              17.3.2. By Treatment Type

              17.3.3. By Type of MPS

              17.3.4. By End User 

       17.4. Market Attractiveness Analysis

18. Market Structure Analysis

       18.1. Market Share Analysis

       18.2. Competition Mapping 

19. Competition Analysis

       19.1. Company Dashboard

       19.2. Company Profile

              19.2.1. Sanofi S.A. 

                      19.2.1.1. Overview

                      19.2.1.2. Service Portfolio

                      19.2.1.3. Analyst Commentary 

              19.2.2. Shire

              19.2.3. BioMarin Pharmaceutical Inc.

              19.2.4. Ultragenyx Pharmaceutical Inc.

              19.2.5. Sarepta Therapeutics

              19.2.6. Abeona Therapeutics, Inc.

              19.2.7. ArmaGen

              19.2.8. Eloxx Pharmaceuticals

              19.2.9. Esteve

              19.2.10. Immusoft Corporation

              19.2.11. Inventiva

              19.2.12. Orchard Therapeutics Limited

              19.2.13. REGENXBIO Inc.

              19.2.14. Sangamo Therapeutics, Inc.

20. Assumptions and Acronyms Used

21. Research Methodology

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote